Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer.

Aspirin use and survival after diagnosis of colorectal cancer. JAMA (2009) 6.93

Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer. JAMA Oncol (2016) 4.90

Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut (2010) 4.01

Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants. JAMA (2015) 3.62

Primary prevention of colorectal cancer. Gastroenterology (2010) 3.20

Aspirin dose and duration of use and risk of colorectal cancer in men. Gastroenterology (2007) 2.73

Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice. Cancer Res (2008) 2.15

The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention. Gut (2012) 2.05

Aspirin in the chemoprevention of colorectal neoplasia: an overview. Cancer Prev Res (Phila) (2011) 2.03

Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence. J Clin Oncol (2012) 1.85

Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy? Br J Cancer (2011) 1.76

Notch post-translationally regulates β-catenin protein in stem and progenitor cells. Nat Cell Biol (2011) 1.66

Aspirin use, 8q24 single nucleotide polymorphism rs6983267, and colorectal cancer according to CTNNB1 alterations. J Natl Cancer Inst (2013) 1.63

Cumulative risk of colon cancer up to age 70 years by risk factor status using data from the Nurses' Health Study. Am J Epidemiol (2009) 1.62

Inflammatory markers are associated with risk of colorectal cancer and chemopreventive response to anti-inflammatory drugs. Gastroenterology (2010) 1.56

Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward. Clin Cancer Res (2010) 1.44

Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis: a cohort study. Ann Intern Med (2012) 1.44

Meta-analyses of colorectal cancer risk factors. Cancer Causes Control (2013) 1.42

Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort. Am J Gastroenterol (2011) 1.34

Long-term use of aspirin and the risk of gastrointestinal bleeding. Am J Med (2011) 1.27

Aspirin as adjuvant therapy for colorectal cancer--reinterpreting paradigms. Nat Rev Clin Oncol (2012) 1.26

Colitis and colitis-associated cancer are exacerbated in mice deficient for tumor protein 53-induced nuclear protein 1. Mol Cell Biol (2007) 1.22

Prediagnostic non-steroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer. Gut (2010) 1.20

Nonsteroidal anti-inflammatory drugs: effects on mortality after colorectal cancer diagnosis. Cancer (2009) 1.19

Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy. J Clin Oncol (2012) 1.17

Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and risk of breast cancer among premenopausal women in the Nurses' Health Study II. Arch Intern Med (2009) 1.10

Aspirin, nonsteroidal anti-inflammatory drugs, acetaminophen, and pancreatic cancer risk: a clinic-based case-control study. Cancer Prev Res (Phila) (2011) 1.08

Platelets and cancer: a casual or causal relationship: revisited. Cancer Metastasis Rev (2014) 1.07

Immune cells: plastic players along colorectal cancer progression. J Cell Mol Med (2013) 1.07

Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD). Sci Transl Med (2014) 1.07

Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study. J Natl Cancer Inst (2009) 1.05

Use of nonsteroidal antiinflammatory agents and incidence of ovarian cancer in 2 large prospective cohorts. Am J Epidemiol (2009) 1.05

Blood 25-hydroxyvitamin D3 concentrations and incident sporadic colorectal adenoma risk: a pooled case-control study. Am J Epidemiol (2010) 1.04

Aspirin and lung cancer risk in a cohort study of women: dosage, duration and latency. Br J Cancer (2007) 1.04

Biomarkers for personalizing omega-3 fatty acid dosing. Cancer Prev Res (Phila) (2014) 1.02

Dose-risk and duration-risk relationships between aspirin and colorectal cancer: a meta-analysis of published cohort studies. PLoS One (2013) 1.01

A prospective study of macrophage inhibitory cytokine-1 (MIC-1/GDF15) and risk of colorectal cancer. J Natl Cancer Inst (2014) 1.00

Common colorectal cancer risk variants in SMAD7 are associated with survival among prediagnostic nonsteroidal anti-inflammatory drug users: a population-based study of postmenopausal women. Genes Chromosomes Cancer (2011) 0.99

Preventability of cancer: the relative contributions of biologic and social and physical environmental determinants of cancer mortality. Annu Rev Public Health (2012) 0.98

Microvessel density is a prognostic marker of human gastric cancer. World J Gastroenterol (2006) 0.98

Pre-diagnostic NSAID use but not hormone therapy is associated with improved colorectal cancer survival in women. Br J Cancer (2011) 0.98

Beyond standard adjuvant therapy for colon cancer: role of nonstandard interventions. Semin Oncol (2011) 0.97

Aspirin for the prevention of colorectal cancer. Best Pract Res Clin Gastroenterol (2011) 0.96

Aspirin and colorectal cancer: back to the future. Clin Cancer Res (2013) 0.95

Long-term aspirin use and colorectal cancer risk: a cohort study in Sweden. Br J Cancer (2006) 0.95

Menopausal hormone therapy use and risk of invasive colon cancer: the California Teachers Study. Am J Epidemiol (2010) 0.92

Pretreatment Neutrophil to Lymphocyte Ratio as a Prognostic Predictor of Urologic Tumors: A Systematic Review and Meta-Analysis. Medicine (Baltimore) (2015) 0.89

Role of phytoestrogens in cancer therapy. Planta Med (2010) 0.89

Non-steroidal anti-inflammatory drugs, acetaminophen, and risk of skin cancer in the Nurses' Health Study. Cancer Causes Control (2012) 0.88

Regular aspirin use and risk of multiple myeloma: a prospective analysis in the health professionals follow-up study and nurses' health study. Cancer Prev Res (Phila) (2013) 0.87

Aspirin use, body mass index, physical activity, plasma C-peptide, and colon cancer risk in US health professionals. Am J Epidemiol (2011) 0.87

Calcium prevents tumorigenesis in a mouse model of colorectal cancer. PLoS One (2011) 0.87

Colorectal cancer after start of nonsteroidal anti-inflammatory drug use. Am J Med (2006) 0.86

Non-steroidal anti-inflammatory drugs and cancer incidence by sex in the VITamins And Lifestyle (VITAL) cohort. Cancer Causes Control (2012) 0.86

Ensuring long-term sustainability of existing cohorts remains the highest priority to inform cancer prevention and control. Cancer Causes Control (2010) 0.86

The association between NSAID use and colorectal cancer mortality: results from the women's health initiative. Cancer Epidemiol Biomarkers Prev (2012) 0.86

Acetylsalicylic Acid reduces the severity of dextran sodium sulfate-induced colitis and increases the formation of anti-inflammatory lipid mediators. Biomed Res Int (2013) 0.84

Metformin for primary colorectal cancer prevention in patients with diabetes: a case-control study in a US population. Cancer (2014) 0.84

Meat consumption, nonsteroidal anti-inflammatory drug use, and mortality among colorectal cancer patients in the California Teachers Study. Cancer Prev Res (Phila) (2010) 0.83

Non-steroidal anti-inflammatory drugs use is associated with reduced risk of inflammation-associated cancers: NIH-AARP study. PLoS One (2014) 0.82

Cyclooxygenase- and lipoxygenase-mediated DNA damage. Cancer Metastasis Rev (2011) 0.82

Nonsteroidal anti-inflammatory drug use and risk of adenomatous and hyperplastic polyps. Cancer Prev Res (Phila) (2011) 0.81

Assessing individual risk for high-risk colorectal adenoma at first-time screening colonoscopy. Int J Cancer (2015) 0.81

Survival after inflammatory bowel disease-associated colorectal cancer in the Colon Cancer Family Registry. World J Gastroenterol (2013) 0.80

Prevention of colorectal cancer and dietary management. Chin Clin Oncol (2013) 0.80

Aspirin and familial adenomatous polyposis: coming full circle. Cancer Prev Res (Phila) (2011) 0.80

The comparison of the clinical manifestations and risk factors of colorectal cancer and adenomas: results from a colonoscopy-based study in southern Chinese. Int J Colorectal Dis (2010) 0.79

Fish consumption and the risk of colorectal cancer: the Ohsaki Cohort Study. Br J Cancer (2009) 0.79

Spectral biomarkers for chemoprevention of colonic neoplasia: a placebo-controlled double-blinded trial with aspirin. Gut (2015) 0.79

Nutrient-Gene Interaction in Colon Cancer, from the Membrane to Cellular Physiology. Annu Rev Nutr (2016) 0.79

Association between Regular Aspirin Use and Circulating Markers of Inflammation: A Study within the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev (2015) 0.79

Use of glucosamine and chondroitin supplements and risk of colorectal cancer. Cancer Causes Control (2013) 0.78

A systematic review of aspirin in primary prevention: is it time for a new approach? Am J Cardiovasc Drugs (2015) 0.78

Concept of chemoprevention in colorectal cancer. World J Gastrointest Oncol (2009) 0.78

Aspirin resistance and other aspirin-related concerns. Neurol Sci (2015) 0.78

Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells. Biologics (2008) 0.78

Inhibition of Radiation-Induced Oxidative Damage in the Lung Tissue: May Acetylsalicylic Acid Have a Positive Role? Inflammation (2016) 0.78

The use of daily aspirin, nutritional supplements and alternative medications among Amish and non-Amish living in Ohio Appalachia. Nutr Cancer (2012) 0.77

Sedentary behaviors and light-intensity activities in relation to colorectal cancer risk. Int J Cancer (2015) 0.77

Chemopreventive drugs: mechanisms via inhibition of cancer stem cells in colorectal cancer. World J Gastroenterol (2014) 0.77

Influence of NSAID Use Among Colorectal Cancer Survivors on Cancer Outcomes. Am J Clin Oncol (2014) 0.77

Migraine history, nonsteroidal anti-inflammatory drug use, and risk of postmenopausal endometrial cancer. Horm Cancer (2012) 0.77

NSAIDs and colorectal cancer risk: do administrative data support a chemopreventive effect? J Gen Intern Med (2007) 0.77

Association of Nonsteroidal Anti-Inflammatory Drugs with Colorectal Cancer by Subgroups in the VITamins and Lifestyle (VITAL) Study. Cancer Epidemiol Biomarkers Prev (2015) 0.77

Secular changes in NSAID use and invasive colorectal cancer incidence: an ecological study. Cancer J (2008) 0.76

Inhibition of the Biosynthesis of Prostaglandin E2 By Low-Dose Aspirin: Implications for Adenocarcinoma Metastasis. Cancer Prev Res (Phila) (2016) 0.76

Pharmacological and dietary prevention for colorectal cancer. BMC Surg (2013) 0.76

Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response? Oncotarget (2016) 0.76

Use of aspirin, non-steroidal anti-inflammatory drugs, and acetaminophen (paracetamol), and risk of psoriasis and psoriatic arthritis: a cohort study. Acta Derm Venereol (2015) 0.76

Management of low-dose aspirin and clopidogrel in clinical practice: a gastrointestinal perspective. J Gastroenterol (2015) 0.76

The Association of Ursodeoxycholic Acid Use With Colorectal Cancer Risk: A Nationwide Cohort Study. Medicine (Baltimore) (2016) 0.76

Perspective: Chemoprevention of colorectal neoplasia: Translating scientific promise into clinical practice. J Carcinog (2011) 0.75

Long-term use of aspirin and risk of colorectal cancer. JAMA (2005) 0.75

Practical implications of nanodosimetry in medicine. Dose Response (2011) 0.75

Critical Overview on the Benefits and Harms of Aspirin. Pharmaceuticals (Basel) (2010) 0.75

Aspirin, salicylates and cancer: report of a meeting at the Royal Society of Medicine, London, 23 November 2010. Ecancermedicalscience (2011) 0.75

Clinical trials update: Tertiary prevention of colorectal cancer. J Carcinog (2011) 0.75

Patient preferences for the chemoprevention of colorectal cancer. Dig Dis Sci (2008) 0.75

Circulating prostaglandins as biomarkers for colorectal cancer? EBioMedicine (2015) 0.75

Thyroid Cancer and Nonsteroidal Anti-Inflammatory Drug Use: A Pooled Analysis of Patients Older Than 40 Years of Age. Thyroid (2015) 0.75

Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol (1985) 26.13

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med (2005) 15.46

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med (2005) 12.46

Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst (2004) 10.61

Aspirin and the risk of colorectal cancer in women. N Engl J Med (1995) 9.59

Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol (1999) 9.34

A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med (2003) 9.18

Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA (2005) 9.03

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology (1994) 8.79

Test of the National Death Index. Am J Epidemiol (1984) 8.46

Aspirin use and reduced risk of fatal colon cancer. N Engl J Med (1991) 7.85

Inhibition of NF-kappa B by sodium salicylate and aspirin. Science (1994) 7.60

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med (2000) 7.54

Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell (1998) 7.25

A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med (2003) 6.99

A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. The Dutch TIA Trial Study Group. N Engl J Med (1991) 5.69

Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med (2004) 5.65

Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med (1994) 5.42

PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell (1999) 5.12

Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci U S A (1997) 4.84

Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ (1995) 4.50

Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology (1994) 4.27

Frequency of analgesic use and risk of hypertension in younger women. Arch Intern Med (2002) 4.21

Aspirin use and risk of fatal cancer. Cancer Res (1993) 4.14

Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med (1999) 4.11

A prospective study of aspirin use and primary prevention of cardiovascular disease in women. JAMA (1991) 3.67

Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Epidemiology (2001) 3.51

A prospective study of aspirin use and the risk for colorectal adenoma. Ann Intern Med (2004) 3.46

Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database. BMJ (2000) 3.10

A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst (1991) 2.96

Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial. Gastroenterology (2003) 2.96

Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc Natl Acad Sci U S A (1998) 2.83

Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst (1993) 2.52

The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry (1991) 2.49

Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer. Arch Intern Med (1994) 2.44

Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer (2003) 2.43

Nonsteroidal antiinflammatory drugs and colorectal cancer. Cancer (1994) 2.42

The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials. Br J Clin Pharmacol (1993) 2.39

Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res (1988) 2.28

Sulindac inhibits activation of the NF-kappaB pathway. J Biol Chem (1999) 2.27

Aspirin. Circulation (2000) 2.26

Platelet-active drugs : the relationships among dose, effectiveness, and side effects. Chest (2001) 2.25

The relationship between cyclooxygenase-2 expression and colorectal cancer. JAMA (1999) 2.24

Risk of colorectal cancer in adenoma-bearing individuals within a defined population. Int J Cancer (1986) 2.22

Postmenopausal hormone use and risk for colorectal cancer and adenoma. Ann Intern Med (1998) 1.96

Lifetime nonnarcotic analgesic use and decline in renal function in women. Arch Intern Med (2004) 1.91

Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing. Br J Cancer (1999) 1.85

Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States). Cancer Causes Control (2003) 1.73

The cyclooxygenase-2-selective inhibitors rofecoxib and celecoxib prevent colorectal neoplasia occurrence and recurrence. Gastroenterology (2003) 1.62

The National Cancer Data Base. Report on colon cancer. Cancer (1996) 1.53

Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: a population-based study. Arch Intern Med (1999) 1.47

Suppression of human colorectal mucosal prostaglandins: determining the lowest effective aspirin dose. J Natl Cancer Inst (1997) 1.40

15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells. Cancer Res (2000) 1.31

Reduced incidence of colorectal adenoma among long-term users of nonsteroidal antiinflammatory drugs: a pooled analysis of published studies and a new population-based study. Epidemiology (2000) 1.30

Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma. Cancer (1998) 1.24

Genetic variants in the UGT1A6 enzyme, aspirin use, and the risk of colorectal adenoma. J Natl Cancer Inst (2005) 1.20

Aspirin use, cancer, and polyps of the large bowel. Cancer (1993) 1.17

Long-term use of nonsteroidal antiinflammatory drugs and other chemopreventors and risk of subsequent colorectal neoplasia. Dig Dis Sci (1996) 1.05

Prospective study of aspirin use and risk of stroke in women. Stroke (1999) 1.04

A prospective study of genetic polymorphisms in the cytochrome P-450 2C9 enzyme and the risk for distal colorectal adenoma. Clin Gastroenterol Hepatol (2004) 1.00

NSAIDs and risk of colorectal cancer according to presence or absence of family history of the disease. Cancer Causes Control (2000) 0.97

Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women. Cancer Epidemiol Biomarkers Prev (1996) 0.97

Drugs and colon cancer. Pharmacoepidemiol Drug Saf (1998) 0.96

Diseases preceding colon cancer. A case-control study among veterans. Dig Dis Sci (1994) 0.95

Aspirin and colorectal cancer. Br J Cancer (1997) 0.94

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol (2003) 12.24

Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int (2003) 9.11

Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med (2007) 9.04

Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med (2013) 7.72

Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. N Engl J Med (2012) 7.47

Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst (2006) 7.19

Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension (2007) 6.99

Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr (2002) 6.96

Aspirin use and survival after diagnosis of colorectal cancer. JAMA (2009) 6.93

Declining mortality in patients with acute renal failure, 1988 to 2002. J Am Soc Nephrol (2006) 6.66

Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation (2003) 6.62

Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int (2004) 6.32

Insulin-like growth factors and neoplasia. Nat Rev Cancer (2004) 6.29

CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut (2008) 6.26

CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature (2008) 6.24

A prospective study of sleep duration and mortality risk in women. Sleep (2004) 6.11

Sensitive sequencing method for KRAS mutation detection by Pyrosequencing. J Mol Diagn (2005) 6.00

Sugar-sweetened beverages and genetic risk of obesity. N Engl J Med (2012) 5.98

Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med (2004) 5.86

New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58

Obesity, weight gain, and the risk of kidney stones. JAMA (2005) 5.34

Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med (2006) 5.24

Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol (2006) 5.22

Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14

Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure. J Am Soc Nephrol (2006) 4.95

Urologic diseases in America project: urolithiasis. J Urol (2005) 4.90

A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89

ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst (2009) 4.72

Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. J Mol Diagn (2006) 4.68

Vasectomy and risk of aggressive prostate cancer: a 24-year follow-up study. J Clin Oncol (2014) 4.67

Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study. J Clin Oncol (2009) 4.54

Habitual caffeine intake and the risk of hypertension in women. JAMA (2005) 4.46

Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication. J Natl Cancer Inst (2013) 4.37

Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol (2006) 4.27

A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. Gastroenterology (2013) 4.06

Comparison of risk factors for colon and rectal cancer. Int J Cancer (2004) 4.03

Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut (2010) 4.01

CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations. J Mol Diagn (2006) 3.98

Association of nut consumption with total and cause-specific mortality. N Engl J Med (2013) 3.94

Diet and lifestyle risk factors associated with incident hypertension in women. JAMA (2009) 3.94

Rotating night shift work and risk of type 2 diabetes: two prospective cohort studies in women. PLoS Med (2011) 3.88

Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology (2011) 3.84

Mortality after hospitalization with mild, moderate, and severe hyponatremia. Am J Med (2009) 3.76

Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69

Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years. J Clin Oncol (2012) 3.63

Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample. J Mol Diagn (2007) 3.56

Zinc supplement use and risk of prostate cancer. J Natl Cancer Inst (2003) 3.54

Restriction of intestinal stem cell expansion and the regenerative response by YAP. Nature (2012) 3.54

A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer. J Natl Cancer Inst (2008) 3.54

A prospective study of aspirin use and the risk of pancreatic cancer in women. J Natl Cancer Inst (2004) 3.49

A prospective study of aspirin use and the risk for colorectal adenoma. Ann Intern Med (2004) 3.46

Prospective study of bevacizumab plus temozolomide in patients with advanced neuroendocrine tumors. J Clin Oncol (2012) 3.36

Activity of sunitinib in patients with advanced neuroendocrine tumors. J Clin Oncol (2008) 3.34

Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. J Natl Cancer Inst (2002) 3.32

A prospective study of plasma selenium levels and prostate cancer risk. J Natl Cancer Inst (2004) 3.32

Patients' perceptions of quality of care for colorectal cancer by race, ethnicity, and language. J Clin Oncol (2005) 3.30

Frequency of analgesic use and risk of hypertension among men. Arch Intern Med (2007) 3.29

PIK3CA mutation is associated with poor prognosis among patients with curatively resected colon cancer. J Clin Oncol (2009) 3.24

History of kidney stones and the risk of coronary heart disease. JAMA (2013) 3.23

Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst (2005) 3.22

Relation of hospital volume to colostomy rates and survival for patients with rectal cancer. J Natl Cancer Inst (2003) 3.21

Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe (2013) 3.21

Primary prevention of colorectal cancer. Gastroenterology (2010) 3.20

Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol (2003) 3.18

Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol (2008) 3.17

Diabetes mellitus and the risk of nephrolithiasis. Kidney Int (2005) 3.17

Social networks, social support, and survival after breast cancer diagnosis. J Clin Oncol (2006) 3.09

Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review. J Pathol (2010) 3.03

Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw (2013) 3.03

Association of hospital procedure volume and outcomes in patients with colon cancer at high risk for recurrence. Ann Intern Med (2003) 3.01

Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin Transl Sci (2008) 2.98

Current issues in measurement and reporting of urinary albumin excretion. Clin Chem (2008) 2.98

Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3? J Clin Oncol (2009) 2.94

Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer. J Natl Cancer Inst (2003) 2.92

Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample. PLoS One (2008) 2.92

Cancer immunology--analysis of host and tumor factors for personalized medicine. Nat Rev Clin Oncol (2011) 2.90

Vitamin D status and incidence of pulmonary tuberculosis, opportunistic infections, and wasting among HIV-infected Tanzanian adults initiating antiretroviral therapy. J Infect Dis (2012) 2.87

LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer. Int J Cancer (2008) 2.87